Stocks Moving in Monday's Pre-Market Session(2)
Gainers
$AMRX.US$ +0.24% rose 9.5% to $4.51 in pre-market trading. The FDA recently approved Amneal Pharmaceuticals Biologics License Application (BLA) for bevacizumab-maly, a biosimilar referencing Avastin.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment